Clinical trials

  • Depemokimab for Eosinophilic granulomatosis with polyangiitis (EGPA)
  • ZAMTOCABTAGENE AUTOLEUCEL for Relapsed/refractory mature B-cell neoplasms | B-cell lymphoma
  • BI 1015550 for Systemic sclerosis-associated interstitial lung disease (SSc-ILD)
  • BIMEKIZUMAB for Moderate to severe plaque psoriasis|Psoriatic arthritis
  • [177Lu]Lu-DOTA-TATE for Glioblastoma
  • N-(4-FLUOROPHENYL)-N-(4-((7-METHOXY-6-(METHYLCARBAMOYL)QUINOLIN-4-YL)OXY)PHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE for Recurrent or metastatic head and neck squamous cell carcinoma
  • LORLATINIB for Non-small cell lung cancer (ALK-positive)
  • DEUCRAVACITINIB for Psoriatic arthritis
  • FARICIMAB for Myopic choroidal neovascularization
  • Linvoseltamab for Relapsed/Refractory Multiple Myeloma | Multiple myeloma
  • GOLCADOMIDE for Relapsed or refractory aggressive large B-cell lymphoma
  • ALLOGENEIC FAECAL MICROBIOTA, POOLED for Recurrent diverticulitis | Acute diverticulitis